Adjuvant Capital

cb Email

Status

ACTIVE

Global HQ

New York, United States

Countries of investment

Investment stages

Series B

Industries

Biotechnology
Health Tech
AI
Fintech

About
Adjuvant Capital is a life sciences investment fund supporting companies developing vaccines, drugs, diagnostics, and devices for global health threats. They fund high-impact technologies tackling neglected diseases and underserved populations worldwide.

Min check size: $5M
Max check size: $50M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Adjuvant Capital finances the most promising life science technologies for highburden public health challenges. They invest in innovative technologies to address highburden and neglected infectious diseases, maternal and child health, nutrition, and reproductive and sexual health.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Top-tier fund concentrating on early-stage life sciences and healthcare investments. Engaged in over 30 deals primarily in North America, with a notable emphasis on biopharmaceuticals and diagnostics. Recognized for operator-led approach and strategic partnerships, facilitating several successful exits through acquisitions and public offerings. Distinctive for its rigorous due diligence and proactive management support.